Do we need to screen for de-novo diabetes mellitus in chronic hepatitis C patients after a sustained virological response?


BACKGROUND AND AIM There are millions of chronic hepatitis C (CHC) virus-infected patients who have been treated with a combination therapy (interferon and ribavirin) and have achieved a virological response (SVR) worldwide. The aim of this study is to evaluate the risk factors for de-novo diabetes mellitus in CHC patients treated with combination therapy… (More)
DOI: 10.1097/MEG.0000000000000929


  • Presentations referencing similar topics